'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A TakeoverInvestors Business Daily • 02/27/23
Seagen's stock surges 15% after a report that Pfizer is in talks to buy the cancer-focused biotechBusiness Insider • 02/27/23
Seagen's stock soars on reported Pfizer buyout interest; Union Pacific shares rally after CEO ousterMarket Watch • 02/27/23
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adultsCNBC • 02/24/23
First RSV Vaccine For Kids—Given To Pregnant Moms—Could Arrive Months Early As FDA Fast-Tracks ReviewForbes • 02/21/23
U.S. FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority ReviewBusiness Wire • 02/21/23
10 dividend stocks with yields as high as 6.5% from a value manager with a strong track recordMarket Watch • 02/17/23
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15GlobeNewsWire • 02/17/23
Pfizer Inc. (PFE) Presents at SVB Securities Global Biopharma Conference (Transcript)Seeking Alpha • 02/16/23
New Migraine Drug Offers Sufferers Hope Of ‘Fast-Acting Relief' Via Nasal Spray, Pfizer SaysForbes • 02/16/23